Skip to main navigation Skip to search Skip to main content

Successful treatment of Sydenham's chorea with intravenous immunoglobulin

  • Nienke Anne Boersma
  • , Herman Schippers
  • , Taco Kuijpers
  • , Jojanneke Heidema*
  • *Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Abstract

We present a case of a 10-year-old girl diagnosed with Sydenham's chorea. Despite treatment with haloperidol and valproic acid for 2 weeks and antibiotics for 5 days, her symptoms continued to worsen. She became severely impaired in daily functioning, as she could barely speak or walk, experienced major feeding difficulties and required help with all daily activities. She was treated with intravenous immunoglobulin (IVIG). Within 4 days, her symptoms started to improve and after 1-month she had fully recovered. This case reminds us that Sydenham's chorea can result in major functional impairment. There is some evidence on the beneficial effect of IVIG in the treatment of Sydenham's chorea, as is evident in our case. Therefore, IVIG should be considered as a treatment option in patients with severe chorea.

Original languageEnglish
Article number211673
Number of pages4
JournalBMJ Case Reports [E]
Volume2016
DOIs
Publication statusPublished - 1 Feb 2016

Fingerprint

Dive into the research topics of 'Successful treatment of Sydenham's chorea with intravenous immunoglobulin'. Together they form a unique fingerprint.

Cite this